NCT04356443 Non-Invasive Monitoring of Respiratory Function in Spontaneously Breathing Patients With COVID-19 Infection Status TERMINATED Phase N/A
NCT04355884 Opportunistic Screening for Asymptomatic Left Ventricular Dysfunction in Coronavirus Disease 2019 (COVID19) Survivors Status UNKNOWN Phase N/A
NCT04355793 Expanded Access Program of Ruxolitinib for the Emergency Treatment of Cytokine Storm From COVID-19 Infection Status NO_LONGER_AVAILABLE Phase N/A
NCT04355611 Epidemiological Characteristics of COVID-19 in Patients With MS or NMO Status COMPLETED Phase N/A
NCT04355494 SOLIRIS® (Eculizumab) Treatment of Participants With COVID-19 Status NO_LONGER_AVAILABLE Phase N/A
NCT04355481 Dissemination of SARS-COV-2 (COVID-19) in the Environment of Infected Patients Admitted to Intensive Care Unit Status UNKNOWN Phase N/A
NCT04355429 Efficacy of Captopril in Covid-19 Patients With Severe Acute Respiratory Syndrome (SARS) CoV-2 Pneumonia (CAPTOCOVID) Status UNKNOWN Phase PHASE2
NCT04355364 Efficacy and Safety of aerosolizedDornase Alfa Administration in Patients With COVID19 Induced ARDS (COVIDORNASE) Status TERMINATED Phase PHASE3
NCT04355338 Assessment of Incidence of SARS-CoV-2 Infection and COVID-19 in Brazil (AVISA) Status COMPLETED Phase N/A
NCT04355247 Prophylactic Corticosteroid to Prevent COVID-19 Cytokine Storm Status UNKNOWN Phase PHASE2
NCT04355143 Colchicine to Reduce Cardiac Injury in COVID-19 (COLHEART-19) Status COMPLETED Phase PHASE2
NCT04355026 Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia Status UNKNOWN Phase PHASE4